Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-21T02:05:25.064Z Has data issue: false hasContentIssue false
  • English
  • Français

P03-348 Agitation and Insomnia During Therapy with Alprazolam: Case Report

Published online by Cambridge University Press:  17 April 2020

O. Kozumplik ,
S. Uzun  and
M. Jakovljevic
O. Kozumplik
Affiliation:
Universitiy Department of Psychiatry, Psychiatric Hospital Vrapce, Croatia
S. Uzun
Affiliation:
Universitiy Department of Psychiatry, Psychiatric Hospital Vrapce, Croatia
M. Jakovljevic
Affiliation:
University Department of Psychiatry, Clinic Hospital Zagreb, Croatia School of Medicine, Zagreb, Croatia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Patient, 43 years old, with diagnoses of posttraumatic stress disorder and recurrent depressive disorder was hospitalized due to worsening of mental condition. At admission he was agitated, depressed, irritable, and presented problems with insomnia. He said that he decided to stop taking antidepressant without consulting his psychiatrist one month earlier because he felt better and he thought he did not need antidepressants any more. During that period he continued taking alprazolam. Soon after discontinuation of antidepressant, his condition worsened, he started feeling tensed, anxious, depressed, and problems with insomnia appeared. He decided to increase the daily dosage of alprazolam from 1,5 mg to 3 mg, but his mental condition deteriorated - he was feeling agitated, irritable, he was depressed and had insomnia. He increased the daily dosage of alprazolam to 4 mg, but his condition was getting worse. He decided to come to hospital because he could not bare such symptoms any longer. After admission, tianeptine was introduced (37,5 mg daily) with zolpidem 10 mg in the evening, and daily dosage of alprazolam was gradually decreased. After this changes in therapy agitation gradually decreased, as well as insomnia. His mood gradually improved. He was discharged after four weeks of hospital treatment.

Type
Psychopharmacological treatment and biological therapies
Information
European Psychiatry , Volume 25 , Issue S1: 18th European Congress of Psychiatry. February 27, March 2, 2010 - Munich, Germany , 2010 , 25-E954
Copyright
Copyright © European Psychiatric Association 2010

References

Uzun, S Kozumplik, O Topić, R Jakovljević, M Depressive disorder and comorbidity: somatic illnes vs. side effect. Psychiatria Danubina 2009; 22(3): 391–398Google Scholar
Uzun, S Kozumplik, O Management of side effects of antidepressants - brief review of recomendations from guidelines for treatment of major depressive disorder. Psychiatria Danubina 2009; 21(1): 91–94Google Scholar
Submit a response

Comments

No Comments have been published for this article.